Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. People
  4. /
  5. Karlton T. Watson
FDA Person
•Office of Biological Products Operations - Division II

Karlton T. Watson

View detailed information about Karlton T. Watson, including compliance records, violations, and related data.

Sign in to open in Dashboard
Person Profile

FDA investigator, Office of Biological Products Operations - Division II. Took part in 1 inspection of 1 company, 2023.

Inspections (1)
DateCompanyClassificationProject areaInspection
December 19, 2023Brammer Bio MA, LLCVAIHuman Cellular, Tissue, and Gene Therapies#1225431
Documents (37)
  • WARNING LETTER · Stemell Inc · March 8, 2019
  • WARNING LETTER · EUCYT Laboratories LLC · November 21, 2019
  • WARNING LETTER · Re-Gen Active Lab, Inc. · July 28, 2021
  • WARNING LETTER · New Mexico Lions Sight Conservation Foundation, Inc. · February 28, 2024
  • 483 · Cal-Maine Foods Inc. · June 17, 2011
  • WARNING LETTER · California IVF Fertility Center · October 11, 2019
  • WARNING LETTER · Vitti Labs, LLC · December 20, 2021
  • WARNING LETTER · Stratus BioSystems, LLC · November 10, 2021
  • WARNING LETTER · Cooper Institute for Advanced Reproductive Medicine · July 19, 2021
  • WARNING LETTER · University Fertility Laboratory, Inc. · February 4, 2019
  • WARNING LETTER · Invitrx Therapeutics Inc. · April 3, 2019
  • WARNING LETTER · American Fertility Medical Center, Genetic Infertility & Andrology Lab · January 22, 2020
  • WARNING LETTER · Emmett F. Branigan, MD, PS, Inc · January 31, 2018
  • WARNING LETTER · Indiana Lions Eye Bank, Inc. (dbA VisionFirst Indiana Lions Eye Bank) · February 1, 2024
  • WARNING LETTER · Utah Cord Bank LLC · February 11, 2021
  • WARNING LETTER · BioLab Sciences, Inc. · September 3, 2021
  • WARNING LETTER · Tenderneeds Fertility LLC · December 13, 2019
  • WARNING LETTER · Invitrx Therapeutics, Inc. · March 22, 2022
  • WARNING LETTER · Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc. · September 25, 2023
  • WARNING LETTER · Westlake IVF, LLC · May 31, 2019
  • WARNING LETTER · Utah Cord Bank LLC · February 11, 2021
  • WARNING LETTER · Family Fertility Center · June 26, 2019
  • WARNING LETTER · Center for Reproductive Health Joliet IVF LLC · February 3, 2017
  • WARNING LETTER · SURGENEX LLC · April 16, 2021
  • WARNING LETTER · Stratus BioSystems, LLC · February 28, 2019
  • WARNING LETTER · Reproductive Technologies, Inc. · August 16, 2019
  • WARNING LETTER · Safari Stem Cell, LLC · May 4, 2023
  • WARNING LETTER · Smart Surgical, Inc · March 5, 2021
  • WARNING LETTER · Liveyon Labs Inc · May 23, 2019
  • WARNING LETTER · The Fertility Partnership LLC · March 5, 2018
  • WARNING LETTER · Signature Biologics, LLC · December 16, 2021
  • WARNING LETTER · Louisville Reproductive Center · June 15, 2017
  • WARNING LETTER · R & B Medical Group Inc. · September 25, 2019
  • EIR · Brenntag Southwest, Inc · October 19, 2012
  • 483 · Brammer Bio MA, LLC · December 19, 2023
  • EIR · Empower Pharmacy · November 25, 2015
  • EIR · Vetter Pharma Fertigung GmbH & Co. KG · December 12, 2014
Frequently inspected with (1)
Priscilla M. Pastrana

investigator

1 shared
Related Office
Office of Biological Products Operations - Division II
Person Information

Name

Karlton T. Watson

Title

Program Division Director

Office

Office of Biological Products Operations - Division II

Role

Regulatory Personnel

ID: fdf2a30c-35e0-4c1b-a676-af1350f55733

Get More Insights

Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.